Literature DB >> 31857365

Long-term outcomes after splenectomy in children with immune thrombocytopenia: an update on the registry data from the Intercontinental Cooperative ITP Study Group.

Maria L Avila1, Nour Amiri1, Eleanor Pullenayegum2, Victor Blanchette1, Paul Imbach3, Thomas Kühne4.   

Abstract

Keywords:  Immune Thrombocytopenic Purpura; Platelets; Splenectomy

Year:  2019        PMID： 31857365      PMCID： PMC7604652          DOI： 10.3324/haematol.2019.236737

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH.

Authors:  S Kaatz; D Ahmad; A C Spyropoulos; S Schulman
Journal:  J Thromb Haemost       Date:  2015-11       Impact factor: 5.824

2.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.

Authors:  Francesco Rodeghiero; Roberto Stasi; Terry Gernsheimer; Marc Michel; Drew Provan; Donald M Arnold; James B Bussel; Douglas B Cines; Beng H Chong; Nichola Cooper; Bertrand Godeau; Klaus Lechner; Maria Gabriella Mazzucconi; Robert McMillan; Miguel A Sanz; Paul Imbach; Victor Blanchette; Thomas Kühne; Marco Ruggeri; James N George
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

3.  Long-term results of splenectomy in adult chronic immune thrombocytopenia.

Authors:  Yue Guan; Shixuan Wang; Feng Xue; Xiaofan Liu; Lei Zhang; Huiyuan Li; Renchi Yang
Journal:  Eur J Haematol       Date:  2016-11-07       Impact factor: 2.997

Review 4.  ITP and international guidelines: what do we know, what do we need?

Authors:  Francesco Rodeghiero; Marco Ruggeri
Journal:  Presse Med       Date:  2014-03-20       Impact factor: 1.228

Review 5.  The pathogenesis of immune thrombocytopaenic purpura.

Authors:  Nichola Cooper; James Bussel
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

Review 6.  Splenectomy for immune thrombocytopenia: down but not out.

Authors:  Shruti Chaturvedi; Donald M Arnold; Keith R McCrae
Journal:  Blood       Date:  2018-01-02       Impact factor: 22.113

7.  Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.

Authors:  S Schulman; C Kearon
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

8.  Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children : Splenectomy in ITP.

Authors:  Rayaz Ahmed; Anup J Devasia; Auro Viswabandya; Kavitha M Lakshmi; Aby Abraham; Sampath Karl; John Mathai; Paul M Jacob; Deepak Abraham; Alok Srivastava; Vikram Mathews; Biju George
Journal:  Ann Hematol       Date:  2016-07-02       Impact factor: 3.673

9.  Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia.

Authors:  Soames Boyle; Richard H White; Ann Brunson; Ted Wun
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

Review 10.  A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

Authors:  Francesco Rodeghiero
Journal:  Br J Haematol       Date:  2018-02-26       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.